Published “Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial” in The Lancet — cited 1,166 times.
- #crossref
- #research
- #work